Literature DB >> 6858128

The 'Alice in Wonderland' experience. Ergot alkaloid therapy for prolactin-secreting pituitary tumors.

R C Williams, C Sherman, M T Buckman.   

Abstract

This discussion was selected from the weekly Grand Rounds in the Department of Medicine, University of New Mexico School of Medicine and Veterans Administration Medical Center, Albuquerque. Taken from a transcription, it has been edited by Drs Charles Sherman, Resident in Medicine, and Maire T. Buckman, Associate Professor of Medicine and Chief, Endocrinology Section, Veterans Administration Medical Center, Alburquerque.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6858128      PMCID： PMC1021476     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


  27 in total

1.  Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.

Authors:  H M Lloyd; J D Meares; J Jacobi
Journal:  Nature       Date:  1975-06-05       Impact factor: 49.962

2.  Experimental studies on the effect of ergocornine methanesulphonate on the luteotrophic function of the rat pituitary gland.

Authors:  G H ZEILMAKER; R A CARLSEN
Journal:  Acta Endocrinol (Copenh)       Date:  1962-11

3.  Prolactin-screening tumors and hypogonadism in 22 men.

Authors:  J N Carter; J E Tyson; G Tolis; S Van Vliet; C Faiman; H G Friesen
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

4.  [Tumour regression in pituitary adenoma by bromocriptin (author's transl)].

Authors:  D Mühlenstedt; F Osmers; H P Schneider
Journal:  Arch Gynecol       Date:  1978-12-29

5.  Dynamic evaluation of prolactin secretion with perphenazine in normal and hyperprolactinemic subjects.

Authors:  M T Buckman; G T Peake
Journal:  Horm Metab Res       Date:  1978-09       Impact factor: 2.936

6.  Radiological evidence for regression of prolactinoma after treatment with bromocriptine.

Authors:  L G Sobrinho; M C Nunes; M A Santos; J C Mauricio
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

7.  Neuroendocrine dysfunction in galactorrhea-amenorrhea after oral contraceptive use.

Authors:  J E Tyson; B Andreasson; J Huth; B Smith; H Zacur
Journal:  Obstet Gynecol       Date:  1975-07       Impact factor: 7.661

8.  Treatment of patients with prolactinomas.

Authors:  K v Werder; R Fahlbusch; R Landgraf; C R Pickardt; H K Rjosk; P C Scriba
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

9.  Prolactinomas and optic nerve compression: disappearance of suprasellar extension and visual recovery after two weeks bromocriptine treatment.

Authors:  N J Woodhouse; F Khouqueer; J O Sieck
Journal:  Horm Res       Date:  1981

10.  Ergot-induced inhibition of pituitary tumor growth in rats.

Authors:  S K Quadri; K H Lu; J Meites
Journal:  Science       Date:  1972-04-28       Impact factor: 47.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.